about
P184
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.Prospects for exosomes in immunotherapy of cancerCalreticulin exposure dictates the immunogenicity of cancer cell deathBleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cellsProspective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patientsThe intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsLiver X receptor β activation induces pyroptosis of human and murine colon cancer cellsT-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalTherapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.Dendritic cells and innate defense against tumor cells.Immunogenicity of anthracyclines: moving towards more personalized medicine.Killer dendritic cells: IKDC and the others.Human FOXP3 and cancer.The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth.Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.Immune ambivalence: The schizophrenic bleomycin.The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.β2-adrenergic stimulation of dendritic cells favors IL-10 secretion by CD4+ T cells.
P50
Q27851740-09E4E583-CAF9-449F-8854-3A35E3B4A433Q28248098-96EB76BE-818E-49FD-A39E-673D27A9D17CQ28280438-CFB8915D-8638-4641-867A-D32F8C421C1BQ28533749-0DC6B858-D88F-4389-A42D-E59913B94BFDQ28542660-E3619270-0E9B-4F6D-BAFF-60D083FBDE90Q31144277-12DD7421-A536-43A4-A844-D4E8101D38D4Q33604925-0D8B4B3D-B31D-4E2B-8668-DC50BA255198Q34486432-6612451B-03D7-4DD8-B199-C4E0015383FBQ35212682-23129AEF-C6C0-47FE-97F4-90133E85C3F1Q36729361-84058415-9FAA-4BE1-81B4-A87E94426037Q36851583-C2B45AFC-1F42-4D45-B8C5-300D3566BCFCQ36915014-434A81A0-DA79-4A3D-9DE9-1455B95C21DDQ37044174-0E82829E-AED1-4031-8381-0F74222B2BB6Q37114351-F5D48E19-FE90-49E5-9036-C7542B245467Q37191524-B3839DF5-B766-4FEB-9E8B-0CFC9D521BA5Q37760416-41BAB877-C61D-4471-8D2B-46D4B86FC986Q38980079-5BC66B09-A10B-4533-83B1-AFD766C61640Q39160299-06429061-35F3-48B8-BFA5-1363BF1212ACQ39234393-302D8991-E57F-4676-AB7C-1D90B4158B5DQ39284974-1D0A138D-239D-43A1-AEC1-13907D001BC8Q39311553-BB98F8D7-5744-44F9-AB9C-76F2BE41FAE5Q39715226-125F1FF5-73D4-4B3B-85F7-2A8AC924C139Q41778516-37B33B2E-E067-42E3-B150-4ECC68F5E3D8Q43292337-976AE29F-69A2-4707-8F6F-349D0CD39085Q46614215-89DF9AC9-047F-47F0-A064-01C17E59CFFAQ47406087-3FE9C120-E7F6-46FF-9AE0-D4B54ABDA608
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Grégoire Mignot
@ast
Grégoire Mignot
@en
Grégoire Mignot
@es
Grégoire Mignot
@fr
Grégoire Mignot
@nl
Grégoire Mignot
@sl
type
label
Grégoire Mignot
@ast
Grégoire Mignot
@en
Grégoire Mignot
@es
Grégoire Mignot
@fr
Grégoire Mignot
@nl
Grégoire Mignot
@sl
prefLabel
Grégoire Mignot
@ast
Grégoire Mignot
@en
Grégoire Mignot
@es
Grégoire Mignot
@fr
Grégoire Mignot
@nl
Grégoire Mignot
@sl
P214
P269
P106
P185
P2038
Gregoire_Mignot
P21
P213
0000 0003 5834 145X
P214
P269
P31
P496
0000-0003-3876-9176
P569
1981-01-01T00:00:00Z
P734
P7859
viaf-204872160